27
Participants
Start Date
September 1, 2019
Primary Completion Date
March 16, 2022
Study Completion Date
March 16, 2022
Placebo
Saline taken by mouth (PO)
Phytocannabinoid cannabidiol (CBD)
CBD taken by mouth (PO)
New York University School of Medicine, New York
National Institutes of Health (NIH)
NIH
Tilray
INDUSTRY
NYU Langone Health
OTHER